Latest Breaking News On - Share premium reserve - Page 2 : comparemela.com

QIAGEN announces plans to return approximately $300 million

Capital return to be conducted through synthetic share repurchase // Return of up to $300 million – maximum approved by shareholders in 2023 – designed to.

Thierry bernardExchange commissionUs securities exchangeLife sciencesFrankfurt prime standardAnnual general meetingChief financial officerShare premium reserveMolecular diagnosticsExchange actAnnual reportNyse qgen

QIAGEN announces plans to return approximately $300 million to shareholders

QIAGEN announces plans to return approximately $300 million to shareholders
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Phoebe lohJohn gilardiThomas theuringerDaniela berheideThierry bernardExchange commissionUs securities exchangeLife sciencesFrankfurt prime standardAnnual general meetingChief financial officerShare premium reserveMolecular diagnosticsExchange actAnnual report

EQS-Adhoc: QIAGEN N V : QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase - adhoc - Börsennachrichten

EQSAdhoc QIAGEN NV Key word Share Buyback QIAGEN NV QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase 07Jan2024 1903 CETCEST Disclosure of an inside inf

Daniele berheideJohn gilardiCorporate communicationsFrankfurt stock exchangeAnnual general meetingShare premium reserveStock exchangeRegulated marketPrime standard

EQS-Adhoc: QIAGEN N V : QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase

EQS-Adhoc: QIAGEN N V : QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

John gilardiDaniele berheideFrankfurt stock exchangeCorporate communicationsAnnual general meetingShare premium reserveStock exchangeRegulated marketPrime standard

EQS-Adhoc: QIAGEN N V : QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase

EQS-Ad-hoc: QIAGEN N.V. / Key word(s): Share Buyback QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a s.

Daniele berheideJohn gilardiFrankfurt stock exchangeCorporate communicationsAnnual general meetingShare premium reserveStock exchangeRegulated marketPrime standard